Literature DB >> 21900201

C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein.

Richard Bisaillon1, Brian T Wilhelm, Jana Krosl, Guy Sauvageau.   

Abstract

The three-amino-acid loop extension (TALE) class homeodomain proteins MEIS1 and PKNOX1 (PREP1) share the ability to interact with PBX and HOX family members and bind similar DNA sequences but appear to play opposing roles in tumor development. Elevated levels of MEIS1 accelerate development of HOX- and MLL-induced leukemias, and this pro-tumorigenic property has been associated with transcriptional activity of MEIS1. In contrast, reduction of PKNOX1 levels has been linked with cancer development despite the absence of an identifiable transactivating domain. In this report, we show that a chimeric protein generated by fusion of the MEIS1 C-terminal region encompassing the transactivating domain with the full-length PKNOX1 (PKNOX1-MC) acquired the ability to accelerate the onset of Hoxa9-induced leukemia in the mouse bone marrow transduction/transplantation model. Gene expression profiling of primary bone marrow cells transduced with Hoxa9 plus Meis1, or Hoxa9 plus Pknox1-MC revealed perturbations in overlapping functional gene subsets implicated in DNA packaging, chromosome organization, and in cell cycle regulation. Together, results presented in this report suggest that the C-terminal domain of MEIS1 confers to PKNOX1 an ectopic transactivating function that promotes leukemogenesis by regulating expression of genes involved in chromatin accessibility and cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900201     DOI: 10.1182/blood-2011-05-354076

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Prep1 and Meis1 competition for Pbx1 binding regulates protein stability and tumorigenesis.

Authors:  Leila Dardaei; Elena Longobardi; Francesco Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-27       Impact factor: 11.205

2.  The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1.

Authors:  Yousaf A Mian; Nancy J Zeleznik-Le
Journal:  Leuk Res       Date:  2016-04-16       Impact factor: 3.156

3.  Cell cycle control in acute myeloid leukemia.

Authors:  Dominik Schnerch; Jasmin Yalcintepe; Andrea Schmidts; Heiko Becker; Marie Follo; Monika Engelhardt; Ralph Wäsch
Journal:  Am J Cancer Res       Date:  2012-08-20       Impact factor: 6.166

Review 4.  Biochemistry of the tale transcription factors PREP, MEIS, and PBX in vertebrates.

Authors:  E Longobardi; D Penkov; D Mateos; G De Florian; M Torres; Francesco Blasi
Journal:  Dev Dyn       Date:  2013-09-02       Impact factor: 3.780

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.